Akademska digitalna zbirka SLovenije - logo
ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents
    Battelino, Tadej
    Continuous subcutaneous insulin infusion (CSII) therapy with technically advanced modern insulin pumps is a treatment option enabling patients and multidisciplinary diabetes teams to achieve all ... current goals for the treatment of children and adolescents with type 1 diabetes mellitus (T1DM): near-normoglycemia, low rate of hypoglycemia, preventing or delaying long-termcomplications and increasing quality of life. Clinical studies demonstrate that CSII therapy reduces glycosylated hemoglobin A1c (HbA1c) witha concomitant decrease in the rate of hypoglycemic events, without excessive weight gain and with an increase of patients' treatment satisfactionin all pediatric age groups. With the development of continuous glucose sensing coupled with an insulin pump, patients can hope for an ever-increasing technological support for the management of insulin therapy inthe foreseeable future.
    Source: Pediatric diabetes. - ISSN 1399-543X (Letn. 7, suppl. 4, 2006, str. 20-24)
    Type of material - article, component part
    Publish date - 2006
    Language - english
    COBISS.SI-ID - 21982169

source: Pediatric diabetes. - ISSN 1399-543X (Letn. 7, suppl. 4, 2006, str. 20-24)
loading ...
loading ...
loading ...